6-amino-2-{ [ (1S)-1-methylbutyl] oxy}-9-[5-(1-piperidinyl)-7,9-dihydro-8Hpurin-8-one maleate

Details for Australian Patent Application No. 2011214468 (hide)

Owner GlaxoSmithKline LLC

Inventors Gibbon, Robert Hermann; Lucas, Amanda; Hermitage, Stephen Andrew

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2011214468

PCT Pub. Number WO2011/098452

Priority 61/303,010 10.02.10 US

Filing date 8 February 2011

Wipo publication date 18 August 2011

International Classifications

C07D 473/18 Heterocyclic compounds containing purine ring systems

A61K 31/522

A61P 11/06 Drugs for disorders of the respiratory system

A61P 29/00 Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61P 31/00 Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 35/00 Antineoplastic agents

A61P 37/08 Drugs for immunological or allergic disorders

Event Publications

9 August 2012 PCT application entered the National Phase

  PCT publication WO2011/098452 Priority application(s): WO2011/098452

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011214470-An animal treating arrangement

2011214465-Methods and compounds for muscle growth